The patients older than 18 years with acute myeloid leukemia after receiving chemotherapy. Acute myeloid leukemia,
Conditions
Interventions
The patients older than 18 years with acute myeloid leukemia after receiving periodic chemotherapy consolidation with HiDAC or IDAC formulations
Diagnostic
The patients older than 18 years with acute myeloid leukemia after receiving chemotherapy.
Sponsors
Siriraj Hospital Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patients older than 18 years with acute myeloid leukemia after receiving periodic chemotherapy consolidation with HiDAC or IDAC formulations
Exclusion criteria
Exclusion criteria: The patients with disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), immune thrombocytopenia (ITP), or systemic lupus erythematosus (SLE) with exacerbation. Patients with hypersplenism. Diagnosed with abnormal bone marrow platelet production, including aplastic anemia (AA), myelodysplastic syndrome (MDS).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Embryo platelet proportion the measurement 2 years Number platelet in AML patients per normal population | — |
Secondary
| Measure | Time frame |
|---|---|
| The recovery of platelet in AML 2 years Number platelet patients per normal ,The recovery of platelet in AML 2 years Number platelet patients per normal | — |
Countries
Thailand
Contacts
Public ContactWeerapat Owattanapanich
Faculty of Medicine, Siriraj Hospital, Mahidol University.
Outcome results
None listed